Global Covid-19 Rapid Antigen Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Covid-19 Rapid Antigen market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Covid-19 Rapid Antigen Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Covid-19 Rapid Antigen market in any manner.
Global Covid-19 Rapid Antigen Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Access Bio
BD
Quidel
Fujirebio
Ellume
OraSure Technologies
Clip Health
Celltrion Healthcare
Salofa Oy
iHealth Labs
Novegent
Hangzhou Alltest Biotech
Guangzhou Decheng Biotechnology
SD Biosensor
MP Biomedical
Jiangsu Well Biotech
CTK Biotech
Hangzhou Laihe Biotech
Innovation Scientific
Biohit Healthcare
ACON Biotech
Assure Tech
Hangzhou Clongene Biotech
Hangzhou Testsea Biotechnology
Market Segmentation (by Type)
Nasal Swab
Oral Fluid/Saliva
Market Segmentation (by Application)
Hospitals
Scientific Research
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Covid-19 Rapid Antigen Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Covid-19 Rapid Antigen market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Covid-19 Rapid Antigen Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Covid-19 Rapid Antigen market in any manner.
Global Covid-19 Rapid Antigen Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Access Bio
BD
Quidel
Fujirebio
Ellume
OraSure Technologies
Clip Health
Celltrion Healthcare
Salofa Oy
iHealth Labs
Novegent
Hangzhou Alltest Biotech
Guangzhou Decheng Biotechnology
SD Biosensor
MP Biomedical
Jiangsu Well Biotech
CTK Biotech
Hangzhou Laihe Biotech
Innovation Scientific
Biohit Healthcare
ACON Biotech
Assure Tech
Hangzhou Clongene Biotech
Hangzhou Testsea Biotechnology
Market Segmentation (by Type)
Nasal Swab
Oral Fluid/Saliva
Market Segmentation (by Application)
Hospitals
Scientific Research
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Covid-19 Rapid Antigen Market
- Overview of the regional outlook of the Covid-19 Rapid Antigen Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Covid-19 Rapid Antigen Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Covid-19 Rapid Antigen
1.2 Key Market Segments
1.2.1 Covid-19 Rapid Antigen Segment by Type
1.2.2 Covid-19 Rapid Antigen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COVID-19 RAPID ANTIGEN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Covid-19 Rapid Antigen Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Covid-19 Rapid Antigen Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COVID-19 RAPID ANTIGEN MARKET COMPETITIVE LANDSCAPE
3.1 Global Covid-19 Rapid Antigen Sales by Manufacturers (2019-2024)
3.2 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2019-2024)
3.3 Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Covid-19 Rapid Antigen Sales Sites, Area Served, Product Type
3.6 Covid-19 Rapid Antigen Market Competitive Situation and Trends
3.6.1 Covid-19 Rapid Antigen Market Concentration Rate
3.6.2 Global 5 and 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COVID-19 RAPID ANTIGEN INDUSTRY CHAIN ANALYSIS
4.1 Covid-19 Rapid Antigen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COVID-19 RAPID ANTIGEN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)
6.3 Global Covid-19 Rapid Antigen Market Size Market Share by Type (2019-2024)
6.4 Global Covid-19 Rapid Antigen Price by Type (2019-2024)
7 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Covid-19 Rapid Antigen Market Sales by Application (2019-2024)
7.3 Global Covid-19 Rapid Antigen Market Size (M USD) by Application (2019-2024)
7.4 Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2019-2024)
8 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY REGION
8.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.2 Global Covid-19 Rapid Antigen Sales Market Share by Region
8.2 North America
8.2.1 North America Covid-19 Rapid Antigen Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Covid-19 Rapid Antigen Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Covid-19 Rapid Antigen Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Covid-19 Rapid Antigen Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Covid-19 Rapid Antigen Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Covid-19 Rapid Antigen Basic Information
9.1.2 Abbott Covid-19 Rapid Antigen Product Overview
9.1.3 Abbott Covid-19 Rapid Antigen Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Covid-19 Rapid Antigen SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Access Bio
9.2.1 Access Bio Covid-19 Rapid Antigen Basic Information
9.2.2 Access Bio Covid-19 Rapid Antigen Product Overview
9.2.3 Access Bio Covid-19 Rapid Antigen Product Market Performance
9.2.4 Access Bio Business Overview
9.2.5 Access Bio Covid-19 Rapid Antigen SWOT Analysis
9.2.6 Access Bio Recent Developments
9.3 BD
9.3.1 BD Covid-19 Rapid Antigen Basic Information
9.3.2 BD Covid-19 Rapid Antigen Product Overview
9.3.3 BD Covid-19 Rapid Antigen Product Market Performance
9.3.4 BD Covid-19 Rapid Antigen SWOT Analysis
9.3.5 BD Business Overview
9.3.6 BD Recent Developments
9.4 Quidel
9.4.1 Quidel Covid-19 Rapid Antigen Basic Information
9.4.2 Quidel Covid-19 Rapid Antigen Product Overview
9.4.3 Quidel Covid-19 Rapid Antigen Product Market Performance
9.4.4 Quidel Business Overview
9.4.5 Quidel Recent Developments
9.5 Fujirebio
9.5.1 Fujirebio Covid-19 Rapid Antigen Basic Information
9.5.2 Fujirebio Covid-19 Rapid Antigen Product Overview
9.5.3 Fujirebio Covid-19 Rapid Antigen Product Market Performance
9.5.4 Fujirebio Business Overview
9.5.5 Fujirebio Recent Developments
9.6 Ellume
9.6.1 Ellume Covid-19 Rapid Antigen Basic Information
9.6.2 Ellume Covid-19 Rapid Antigen Product Overview
9.6.3 Ellume Covid-19 Rapid Antigen Product Market Performance
9.6.4 Ellume Business Overview
9.6.5 Ellume Recent Developments
9.7 OraSure Technologies
9.7.1 OraSure Technologies Covid-19 Rapid Antigen Basic Information
9.7.2 OraSure Technologies Covid-19 Rapid Antigen Product Overview
9.7.3 OraSure Technologies Covid-19 Rapid Antigen Product Market Performance
9.7.4 OraSure Technologies Business Overview
9.7.5 OraSure Technologies Recent Developments
9.8 Clip Health
9.8.1 Clip Health Covid-19 Rapid Antigen Basic Information
9.8.2 Clip Health Covid-19 Rapid Antigen Product Overview
9.8.3 Clip Health Covid-19 Rapid Antigen Product Market Performance
9.8.4 Clip Health Business Overview
9.8.5 Clip Health Recent Developments
9.9 Celltrion Healthcare
9.9.1 Celltrion Healthcare Covid-19 Rapid Antigen Basic Information
9.9.2 Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
9.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Product Market Performance
9.9.4 Celltrion Healthcare Business Overview
9.9.5 Celltrion Healthcare Recent Developments
9.10 Salofa Oy
9.10.1 Salofa Oy Covid-19 Rapid Antigen Basic Information
9.10.2 Salofa Oy Covid-19 Rapid Antigen Product Overview
9.10.3 Salofa Oy Covid-19 Rapid Antigen Product Market Performance
9.10.4 Salofa Oy Business Overview
9.10.5 Salofa Oy Recent Developments
9.11 iHealth Labs
9.11.1 iHealth Labs Covid-19 Rapid Antigen Basic Information
9.11.2 iHealth Labs Covid-19 Rapid Antigen Product Overview
9.11.3 iHealth Labs Covid-19 Rapid Antigen Product Market Performance
9.11.4 iHealth Labs Business Overview
9.11.5 iHealth Labs Recent Developments
9.12 Novegent
9.12.1 Novegent Covid-19 Rapid Antigen Basic Information
9.12.2 Novegent Covid-19 Rapid Antigen Product Overview
9.12.3 Novegent Covid-19 Rapid Antigen Product Market Performance
9.12.4 Novegent Business Overview
9.12.5 Novegent Recent Developments
9.13 Hangzhou Alltest Biotech
9.13.1 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Basic Information
9.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
9.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Market Performance
9.13.4 Hangzhou Alltest Biotech Business Overview
9.13.5 Hangzhou Alltest Biotech Recent Developments
9.14 Guangzhou Decheng Biotechnology
9.14.1 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Basic Information
9.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
9.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Market Performance
9.14.4 Guangzhou Decheng Biotechnology Business Overview
9.14.5 Guangzhou Decheng Biotechnology Recent Developments
9.15 SD Biosensor
9.15.1 SD Biosensor Covid-19 Rapid Antigen Basic Information
9.15.2 SD Biosensor Covid-19 Rapid Antigen Product Overview
9.15.3 SD Biosensor Covid-19 Rapid Antigen Product Market Performance
9.15.4 SD Biosensor Business Overview
9.15.5 SD Biosensor Recent Developments
9.16 MP Biomedical
9.16.1 MP Biomedical Covid-19 Rapid Antigen Basic Information
9.16.2 MP Biomedical Covid-19 Rapid Antigen Product Overview
9.16.3 MP Biomedical Covid-19 Rapid Antigen Product Market Performance
9.16.4 MP Biomedical Business Overview
9.16.5 MP Biomedical Recent Developments
9.17 Jiangsu Well Biotech
9.17.1 Jiangsu Well Biotech Covid-19 Rapid Antigen Basic Information
9.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
9.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Market Performance
9.17.4 Jiangsu Well Biotech Business Overview
9.17.5 Jiangsu Well Biotech Recent Developments
9.18 CTK Biotech
9.18.1 CTK Biotech Covid-19 Rapid Antigen Basic Information
9.18.2 CTK Biotech Covid-19 Rapid Antigen Product Overview
9.18.3 CTK Biotech Covid-19 Rapid Antigen Product Market Performance
9.18.4 CTK Biotech Business Overview
9.18.5 CTK Biotech Recent Developments
9.19 Hangzhou Laihe Biotech
9.19.1 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Basic Information
9.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
9.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Market Performance
9.19.4 Hangzhou Laihe Biotech Business Overview
9.19.5 Hangzhou Laihe Biotech Recent Developments
9.20 Innovation Scientific
9.20.1 Innovation Scientific Covid-19 Rapid Antigen Basic Information
9.20.2 Innovation Scientific Covid-19 Rapid Antigen Product Overview
9.20.3 Innovation Scientific Covid-19 Rapid Antigen Product Market Performance
9.20.4 Innovation Scientific Business Overview
9.20.5 Innovation Scientific Recent Developments
9.21 Biohit Healthcare
9.21.1 Biohit Healthcare Covid-19 Rapid Antigen Basic Information
9.21.2 Biohit Healthcare Covid-19 Rapid Antigen Product Overview
9.21.3 Biohit Healthcare Covid-19 Rapid Antigen Product Market Performance
9.21.4 Biohit Healthcare Business Overview
9.21.5 Biohit Healthcare Recent Developments
9.22 ACON Biotech
9.22.1 ACON Biotech Covid-19 Rapid Antigen Basic Information
9.22.2 ACON Biotech Covid-19 Rapid Antigen Product Overview
9.22.3 ACON Biotech Covid-19 Rapid Antigen Product Market Performance
9.22.4 ACON Biotech Business Overview
9.22.5 ACON Biotech Recent Developments
9.23 Assure Tech
9.23.1 Assure Tech Covid-19 Rapid Antigen Basic Information
9.23.2 Assure Tech Covid-19 Rapid Antigen Product Overview
9.23.3 Assure Tech Covid-19 Rapid Antigen Product Market Performance
9.23.4 Assure Tech Business Overview
9.23.5 Assure Tech Recent Developments
9.24 Hangzhou Clongene Biotech
9.24.1 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Basic Information
9.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
9.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Market Performance
9.24.4 Hangzhou Clongene Biotech Business Overview
9.24.5 Hangzhou Clongene Biotech Recent Developments
9.25 Hangzhou Testsea Biotechnology
9.25.1 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Basic Information
9.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
9.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Market Performance
9.25.4 Hangzhou Testsea Biotechnology Business Overview
9.25.5 Hangzhou Testsea Biotechnology Recent Developments
10 COVID-19 RAPID ANTIGEN MARKET FORECAST BY REGION
10.1 Global Covid-19 Rapid Antigen Market Size Forecast
10.2 Global Covid-19 Rapid Antigen Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Covid-19 Rapid Antigen Market Size Forecast by Country
10.2.3 Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region
10.2.4 South America Covid-19 Rapid Antigen Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Covid-19 Rapid Antigen by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Covid-19 Rapid Antigen Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Type (2025-2030)
11.1.2 Global Covid-19 Rapid Antigen Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Covid-19 Rapid Antigen by Type (2025-2030)
11.2 Global Covid-19 Rapid Antigen Market Forecast by Application (2025-2030)
11.2.1 Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application
11.2.2 Global Covid-19 Rapid Antigen Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Covid-19 Rapid Antigen
1.2 Key Market Segments
1.2.1 Covid-19 Rapid Antigen Segment by Type
1.2.2 Covid-19 Rapid Antigen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COVID-19 RAPID ANTIGEN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Covid-19 Rapid Antigen Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Covid-19 Rapid Antigen Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COVID-19 RAPID ANTIGEN MARKET COMPETITIVE LANDSCAPE
3.1 Global Covid-19 Rapid Antigen Sales by Manufacturers (2019-2024)
3.2 Global Covid-19 Rapid Antigen Revenue Market Share by Manufacturers (2019-2024)
3.3 Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Covid-19 Rapid Antigen Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Covid-19 Rapid Antigen Sales Sites, Area Served, Product Type
3.6 Covid-19 Rapid Antigen Market Competitive Situation and Trends
3.6.1 Covid-19 Rapid Antigen Market Concentration Rate
3.6.2 Global 5 and 10 Largest Covid-19 Rapid Antigen Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COVID-19 RAPID ANTIGEN INDUSTRY CHAIN ANALYSIS
4.1 Covid-19 Rapid Antigen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COVID-19 RAPID ANTIGEN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)
6.3 Global Covid-19 Rapid Antigen Market Size Market Share by Type (2019-2024)
6.4 Global Covid-19 Rapid Antigen Price by Type (2019-2024)
7 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Covid-19 Rapid Antigen Market Sales by Application (2019-2024)
7.3 Global Covid-19 Rapid Antigen Market Size (M USD) by Application (2019-2024)
7.4 Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2019-2024)
8 COVID-19 RAPID ANTIGEN MARKET SEGMENTATION BY REGION
8.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.1 Global Covid-19 Rapid Antigen Sales by Region
8.1.2 Global Covid-19 Rapid Antigen Sales Market Share by Region
8.2 North America
8.2.1 North America Covid-19 Rapid Antigen Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Covid-19 Rapid Antigen Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Covid-19 Rapid Antigen Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Covid-19 Rapid Antigen Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Covid-19 Rapid Antigen Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Covid-19 Rapid Antigen Basic Information
9.1.2 Abbott Covid-19 Rapid Antigen Product Overview
9.1.3 Abbott Covid-19 Rapid Antigen Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Covid-19 Rapid Antigen SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Access Bio
9.2.1 Access Bio Covid-19 Rapid Antigen Basic Information
9.2.2 Access Bio Covid-19 Rapid Antigen Product Overview
9.2.3 Access Bio Covid-19 Rapid Antigen Product Market Performance
9.2.4 Access Bio Business Overview
9.2.5 Access Bio Covid-19 Rapid Antigen SWOT Analysis
9.2.6 Access Bio Recent Developments
9.3 BD
9.3.1 BD Covid-19 Rapid Antigen Basic Information
9.3.2 BD Covid-19 Rapid Antigen Product Overview
9.3.3 BD Covid-19 Rapid Antigen Product Market Performance
9.3.4 BD Covid-19 Rapid Antigen SWOT Analysis
9.3.5 BD Business Overview
9.3.6 BD Recent Developments
9.4 Quidel
9.4.1 Quidel Covid-19 Rapid Antigen Basic Information
9.4.2 Quidel Covid-19 Rapid Antigen Product Overview
9.4.3 Quidel Covid-19 Rapid Antigen Product Market Performance
9.4.4 Quidel Business Overview
9.4.5 Quidel Recent Developments
9.5 Fujirebio
9.5.1 Fujirebio Covid-19 Rapid Antigen Basic Information
9.5.2 Fujirebio Covid-19 Rapid Antigen Product Overview
9.5.3 Fujirebio Covid-19 Rapid Antigen Product Market Performance
9.5.4 Fujirebio Business Overview
9.5.5 Fujirebio Recent Developments
9.6 Ellume
9.6.1 Ellume Covid-19 Rapid Antigen Basic Information
9.6.2 Ellume Covid-19 Rapid Antigen Product Overview
9.6.3 Ellume Covid-19 Rapid Antigen Product Market Performance
9.6.4 Ellume Business Overview
9.6.5 Ellume Recent Developments
9.7 OraSure Technologies
9.7.1 OraSure Technologies Covid-19 Rapid Antigen Basic Information
9.7.2 OraSure Technologies Covid-19 Rapid Antigen Product Overview
9.7.3 OraSure Technologies Covid-19 Rapid Antigen Product Market Performance
9.7.4 OraSure Technologies Business Overview
9.7.5 OraSure Technologies Recent Developments
9.8 Clip Health
9.8.1 Clip Health Covid-19 Rapid Antigen Basic Information
9.8.2 Clip Health Covid-19 Rapid Antigen Product Overview
9.8.3 Clip Health Covid-19 Rapid Antigen Product Market Performance
9.8.4 Clip Health Business Overview
9.8.5 Clip Health Recent Developments
9.9 Celltrion Healthcare
9.9.1 Celltrion Healthcare Covid-19 Rapid Antigen Basic Information
9.9.2 Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
9.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Product Market Performance
9.9.4 Celltrion Healthcare Business Overview
9.9.5 Celltrion Healthcare Recent Developments
9.10 Salofa Oy
9.10.1 Salofa Oy Covid-19 Rapid Antigen Basic Information
9.10.2 Salofa Oy Covid-19 Rapid Antigen Product Overview
9.10.3 Salofa Oy Covid-19 Rapid Antigen Product Market Performance
9.10.4 Salofa Oy Business Overview
9.10.5 Salofa Oy Recent Developments
9.11 iHealth Labs
9.11.1 iHealth Labs Covid-19 Rapid Antigen Basic Information
9.11.2 iHealth Labs Covid-19 Rapid Antigen Product Overview
9.11.3 iHealth Labs Covid-19 Rapid Antigen Product Market Performance
9.11.4 iHealth Labs Business Overview
9.11.5 iHealth Labs Recent Developments
9.12 Novegent
9.12.1 Novegent Covid-19 Rapid Antigen Basic Information
9.12.2 Novegent Covid-19 Rapid Antigen Product Overview
9.12.3 Novegent Covid-19 Rapid Antigen Product Market Performance
9.12.4 Novegent Business Overview
9.12.5 Novegent Recent Developments
9.13 Hangzhou Alltest Biotech
9.13.1 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Basic Information
9.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
9.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Market Performance
9.13.4 Hangzhou Alltest Biotech Business Overview
9.13.5 Hangzhou Alltest Biotech Recent Developments
9.14 Guangzhou Decheng Biotechnology
9.14.1 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Basic Information
9.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
9.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Market Performance
9.14.4 Guangzhou Decheng Biotechnology Business Overview
9.14.5 Guangzhou Decheng Biotechnology Recent Developments
9.15 SD Biosensor
9.15.1 SD Biosensor Covid-19 Rapid Antigen Basic Information
9.15.2 SD Biosensor Covid-19 Rapid Antigen Product Overview
9.15.3 SD Biosensor Covid-19 Rapid Antigen Product Market Performance
9.15.4 SD Biosensor Business Overview
9.15.5 SD Biosensor Recent Developments
9.16 MP Biomedical
9.16.1 MP Biomedical Covid-19 Rapid Antigen Basic Information
9.16.2 MP Biomedical Covid-19 Rapid Antigen Product Overview
9.16.3 MP Biomedical Covid-19 Rapid Antigen Product Market Performance
9.16.4 MP Biomedical Business Overview
9.16.5 MP Biomedical Recent Developments
9.17 Jiangsu Well Biotech
9.17.1 Jiangsu Well Biotech Covid-19 Rapid Antigen Basic Information
9.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
9.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Market Performance
9.17.4 Jiangsu Well Biotech Business Overview
9.17.5 Jiangsu Well Biotech Recent Developments
9.18 CTK Biotech
9.18.1 CTK Biotech Covid-19 Rapid Antigen Basic Information
9.18.2 CTK Biotech Covid-19 Rapid Antigen Product Overview
9.18.3 CTK Biotech Covid-19 Rapid Antigen Product Market Performance
9.18.4 CTK Biotech Business Overview
9.18.5 CTK Biotech Recent Developments
9.19 Hangzhou Laihe Biotech
9.19.1 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Basic Information
9.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
9.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Market Performance
9.19.4 Hangzhou Laihe Biotech Business Overview
9.19.5 Hangzhou Laihe Biotech Recent Developments
9.20 Innovation Scientific
9.20.1 Innovation Scientific Covid-19 Rapid Antigen Basic Information
9.20.2 Innovation Scientific Covid-19 Rapid Antigen Product Overview
9.20.3 Innovation Scientific Covid-19 Rapid Antigen Product Market Performance
9.20.4 Innovation Scientific Business Overview
9.20.5 Innovation Scientific Recent Developments
9.21 Biohit Healthcare
9.21.1 Biohit Healthcare Covid-19 Rapid Antigen Basic Information
9.21.2 Biohit Healthcare Covid-19 Rapid Antigen Product Overview
9.21.3 Biohit Healthcare Covid-19 Rapid Antigen Product Market Performance
9.21.4 Biohit Healthcare Business Overview
9.21.5 Biohit Healthcare Recent Developments
9.22 ACON Biotech
9.22.1 ACON Biotech Covid-19 Rapid Antigen Basic Information
9.22.2 ACON Biotech Covid-19 Rapid Antigen Product Overview
9.22.3 ACON Biotech Covid-19 Rapid Antigen Product Market Performance
9.22.4 ACON Biotech Business Overview
9.22.5 ACON Biotech Recent Developments
9.23 Assure Tech
9.23.1 Assure Tech Covid-19 Rapid Antigen Basic Information
9.23.2 Assure Tech Covid-19 Rapid Antigen Product Overview
9.23.3 Assure Tech Covid-19 Rapid Antigen Product Market Performance
9.23.4 Assure Tech Business Overview
9.23.5 Assure Tech Recent Developments
9.24 Hangzhou Clongene Biotech
9.24.1 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Basic Information
9.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
9.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Market Performance
9.24.4 Hangzhou Clongene Biotech Business Overview
9.24.5 Hangzhou Clongene Biotech Recent Developments
9.25 Hangzhou Testsea Biotechnology
9.25.1 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Basic Information
9.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
9.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Market Performance
9.25.4 Hangzhou Testsea Biotechnology Business Overview
9.25.5 Hangzhou Testsea Biotechnology Recent Developments
10 COVID-19 RAPID ANTIGEN MARKET FORECAST BY REGION
10.1 Global Covid-19 Rapid Antigen Market Size Forecast
10.2 Global Covid-19 Rapid Antigen Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Covid-19 Rapid Antigen Market Size Forecast by Country
10.2.3 Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region
10.2.4 South America Covid-19 Rapid Antigen Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Covid-19 Rapid Antigen by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Covid-19 Rapid Antigen Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Covid-19 Rapid Antigen by Type (2025-2030)
11.1.2 Global Covid-19 Rapid Antigen Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Covid-19 Rapid Antigen by Type (2025-2030)
11.2 Global Covid-19 Rapid Antigen Market Forecast by Application (2025-2030)
11.2.1 Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application
11.2.2 Global Covid-19 Rapid Antigen Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Covid-19 Rapid Antigen Market Size Comparison by Region (M USD)
Table 5. Global Covid-19 Rapid Antigen Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Covid-19 Rapid Antigen Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Antigen as of 2022)
Table 10. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Covid-19 Rapid Antigen Sales Sites and Area Served
Table 12. Manufacturers Covid-19 Rapid Antigen Product Type
Table 13. Global Covid-19 Rapid Antigen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Covid-19 Rapid Antigen
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Covid-19 Rapid Antigen Market Challenges
Table 22. Global Covid-19 Rapid Antigen Sales by Type (K Units)
Table 23. Global Covid-19 Rapid Antigen Market Size by Type (M USD)
Table 24. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2019-2024)
Table 25. Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)
Table 26. Global Covid-19 Rapid Antigen Market Size (M USD) by Type (2019-2024)
Table 27. Global Covid-19 Rapid Antigen Market Size Share by Type (2019-2024)
Table 28. Global Covid-19 Rapid Antigen Price (USD/Unit) by Type (2019-2024)
Table 29. Global Covid-19 Rapid Antigen Sales (K Units) by Application
Table 30. Global Covid-19 Rapid Antigen Market Size by Application
Table 31. Global Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)
Table 32. Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)
Table 33. Global Covid-19 Rapid Antigen Sales by Application (2019-2024) & (M USD)
Table 34. Global Covid-19 Rapid Antigen Market Share by Application (2019-2024)
Table 35. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2019-2024)
Table 36. Global Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 37. Global Covid-19 Rapid Antigen Sales Market Share by Region (2019-2024)
Table 38. North America Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 39. Europe Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 41. South America Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Covid-19 Rapid Antigen Basic Information
Table 44. Abbott Covid-19 Rapid Antigen Product Overview
Table 45. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Covid-19 Rapid Antigen SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Access Bio Covid-19 Rapid Antigen Basic Information
Table 50. Access Bio Covid-19 Rapid Antigen Product Overview
Table 51. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Access Bio Business Overview
Table 53. Access Bio Covid-19 Rapid Antigen SWOT Analysis
Table 54. Access Bio Recent Developments
Table 55. BD Covid-19 Rapid Antigen Basic Information
Table 56. BD Covid-19 Rapid Antigen Product Overview
Table 57. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BD Covid-19 Rapid Antigen SWOT Analysis
Table 59. BD Business Overview
Table 60. BD Recent Developments
Table 61. Quidel Covid-19 Rapid Antigen Basic Information
Table 62. Quidel Covid-19 Rapid Antigen Product Overview
Table 63. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Quidel Business Overview
Table 65. Quidel Recent Developments
Table 66. Fujirebio Covid-19 Rapid Antigen Basic Information
Table 67. Fujirebio Covid-19 Rapid Antigen Product Overview
Table 68. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fujirebio Business Overview
Table 70. Fujirebio Recent Developments
Table 71. Ellume Covid-19 Rapid Antigen Basic Information
Table 72. Ellume Covid-19 Rapid Antigen Product Overview
Table 73. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Ellume Business Overview
Table 75. Ellume Recent Developments
Table 76. OraSure Technologies Covid-19 Rapid Antigen Basic Information
Table 77. OraSure Technologies Covid-19 Rapid Antigen Product Overview
Table 78. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. OraSure Technologies Business Overview
Table 80. OraSure Technologies Recent Developments
Table 81. Clip Health Covid-19 Rapid Antigen Basic Information
Table 82. Clip Health Covid-19 Rapid Antigen Product Overview
Table 83. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Clip Health Business Overview
Table 85. Clip Health Recent Developments
Table 86. Celltrion Healthcare Covid-19 Rapid Antigen Basic Information
Table 87. Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
Table 88. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Celltrion Healthcare Business Overview
Table 90. Celltrion Healthcare Recent Developments
Table 91. Salofa Oy Covid-19 Rapid Antigen Basic Information
Table 92. Salofa Oy Covid-19 Rapid Antigen Product Overview
Table 93. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Salofa Oy Business Overview
Table 95. Salofa Oy Recent Developments
Table 96. iHealth Labs Covid-19 Rapid Antigen Basic Information
Table 97. iHealth Labs Covid-19 Rapid Antigen Product Overview
Table 98. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. iHealth Labs Business Overview
Table 100. iHealth Labs Recent Developments
Table 101. Novegent Covid-19 Rapid Antigen Basic Information
Table 102. Novegent Covid-19 Rapid Antigen Product Overview
Table 103. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Novegent Business Overview
Table 105. Novegent Recent Developments
Table 106. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Basic Information
Table 107. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
Table 108. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Hangzhou Alltest Biotech Business Overview
Table 110. Hangzhou Alltest Biotech Recent Developments
Table 111. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Basic Information
Table 112. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
Table 113. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Guangzhou Decheng Biotechnology Business Overview
Table 115. Guangzhou Decheng Biotechnology Recent Developments
Table 116. SD Biosensor Covid-19 Rapid Antigen Basic Information
Table 117. SD Biosensor Covid-19 Rapid Antigen Product Overview
Table 118. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. SD Biosensor Business Overview
Table 120. SD Biosensor Recent Developments
Table 121. MP Biomedical Covid-19 Rapid Antigen Basic Information
Table 122. MP Biomedical Covid-19 Rapid Antigen Product Overview
Table 123. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. MP Biomedical Business Overview
Table 125. MP Biomedical Recent Developments
Table 126. Jiangsu Well Biotech Covid-19 Rapid Antigen Basic Information
Table 127. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
Table 128. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Jiangsu Well Biotech Business Overview
Table 130. Jiangsu Well Biotech Recent Developments
Table 131. CTK Biotech Covid-19 Rapid Antigen Basic Information
Table 132. CTK Biotech Covid-19 Rapid Antigen Product Overview
Table 133. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. CTK Biotech Business Overview
Table 135. CTK Biotech Recent Developments
Table 136. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Basic Information
Table 137. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
Table 138. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Hangzhou Laihe Biotech Business Overview
Table 140. Hangzhou Laihe Biotech Recent Developments
Table 141. Innovation Scientific Covid-19 Rapid Antigen Basic Information
Table 142. Innovation Scientific Covid-19 Rapid Antigen Product Overview
Table 143. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Innovation Scientific Business Overview
Table 145. Innovation Scientific Recent Developments
Table 146. Biohit Healthcare Covid-19 Rapid Antigen Basic Information
Table 147. Biohit Healthcare Covid-19 Rapid Antigen Product Overview
Table 148. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Biohit Healthcare Business Overview
Table 150. Biohit Healthcare Recent Developments
Table 151. ACON Biotech Covid-19 Rapid Antigen Basic Information
Table 152. ACON Biotech Covid-19 Rapid Antigen Product Overview
Table 153. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. ACON Biotech Business Overview
Table 155. ACON Biotech Recent Developments
Table 156. Assure Tech Covid-19 Rapid Antigen Basic Information
Table 157. Assure Tech Covid-19 Rapid Antigen Product Overview
Table 158. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Assure Tech Business Overview
Table 160. Assure Tech Recent Developments
Table 161. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Basic Information
Table 162. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
Table 163. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Hangzhou Clongene Biotech Business Overview
Table 165. Hangzhou Clongene Biotech Recent Developments
Table 166. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Basic Information
Table 167. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
Table 168. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Hangzhou Testsea Biotechnology Business Overview
Table 170. Hangzhou Testsea Biotechnology Recent Developments
Table 171. Global Covid-19 Rapid Antigen Sales Forecast by Region (2025-2030) & (K Units)
Table 172. Global Covid-19 Rapid Antigen Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)
Table 174. North America Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)
Table 176. Europe Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Covid-19 Rapid Antigen Sales Forecast by Region (2025-2030) & (K Units)
Table 178. Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)
Table 180. South America Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Covid-19 Rapid Antigen Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Covid-19 Rapid Antigen Sales Forecast by Type (2025-2030) & (K Units)
Table 184. Global Covid-19 Rapid Antigen Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Covid-19 Rapid Antigen Price Forecast by Type (2025-2030) & (USD/Unit)
Table 186. Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application (2025-2030)
Table 187. Global Covid-19 Rapid Antigen Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Covid-19 Rapid Antigen Market Size Comparison by Region (M USD)
Table 5. Global Covid-19 Rapid Antigen Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Covid-19 Rapid Antigen Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Covid-19 Rapid Antigen Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Antigen as of 2022)
Table 10. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Covid-19 Rapid Antigen Sales Sites and Area Served
Table 12. Manufacturers Covid-19 Rapid Antigen Product Type
Table 13. Global Covid-19 Rapid Antigen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Covid-19 Rapid Antigen
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Covid-19 Rapid Antigen Market Challenges
Table 22. Global Covid-19 Rapid Antigen Sales by Type (K Units)
Table 23. Global Covid-19 Rapid Antigen Market Size by Type (M USD)
Table 24. Global Covid-19 Rapid Antigen Sales (K Units) by Type (2019-2024)
Table 25. Global Covid-19 Rapid Antigen Sales Market Share by Type (2019-2024)
Table 26. Global Covid-19 Rapid Antigen Market Size (M USD) by Type (2019-2024)
Table 27. Global Covid-19 Rapid Antigen Market Size Share by Type (2019-2024)
Table 28. Global Covid-19 Rapid Antigen Price (USD/Unit) by Type (2019-2024)
Table 29. Global Covid-19 Rapid Antigen Sales (K Units) by Application
Table 30. Global Covid-19 Rapid Antigen Market Size by Application
Table 31. Global Covid-19 Rapid Antigen Sales by Application (2019-2024) & (K Units)
Table 32. Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)
Table 33. Global Covid-19 Rapid Antigen Sales by Application (2019-2024) & (M USD)
Table 34. Global Covid-19 Rapid Antigen Market Share by Application (2019-2024)
Table 35. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2019-2024)
Table 36. Global Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 37. Global Covid-19 Rapid Antigen Sales Market Share by Region (2019-2024)
Table 38. North America Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 39. Europe Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 41. South America Covid-19 Rapid Antigen Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Covid-19 Rapid Antigen Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Covid-19 Rapid Antigen Basic Information
Table 44. Abbott Covid-19 Rapid Antigen Product Overview
Table 45. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Covid-19 Rapid Antigen SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Access Bio Covid-19 Rapid Antigen Basic Information
Table 50. Access Bio Covid-19 Rapid Antigen Product Overview
Table 51. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Access Bio Business Overview
Table 53. Access Bio Covid-19 Rapid Antigen SWOT Analysis
Table 54. Access Bio Recent Developments
Table 55. BD Covid-19 Rapid Antigen Basic Information
Table 56. BD Covid-19 Rapid Antigen Product Overview
Table 57. BD Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BD Covid-19 Rapid Antigen SWOT Analysis
Table 59. BD Business Overview
Table 60. BD Recent Developments
Table 61. Quidel Covid-19 Rapid Antigen Basic Information
Table 62. Quidel Covid-19 Rapid Antigen Product Overview
Table 63. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Quidel Business Overview
Table 65. Quidel Recent Developments
Table 66. Fujirebio Covid-19 Rapid Antigen Basic Information
Table 67. Fujirebio Covid-19 Rapid Antigen Product Overview
Table 68. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fujirebio Business Overview
Table 70. Fujirebio Recent Developments
Table 71. Ellume Covid-19 Rapid Antigen Basic Information
Table 72. Ellume Covid-19 Rapid Antigen Product Overview
Table 73. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Ellume Business Overview
Table 75. Ellume Recent Developments
Table 76. OraSure Technologies Covid-19 Rapid Antigen Basic Information
Table 77. OraSure Technologies Covid-19 Rapid Antigen Product Overview
Table 78. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. OraSure Technologies Business Overview
Table 80. OraSure Technologies Recent Developments
Table 81. Clip Health Covid-19 Rapid Antigen Basic Information
Table 82. Clip Health Covid-19 Rapid Antigen Product Overview
Table 83. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Clip Health Business Overview
Table 85. Clip Health Recent Developments
Table 86. Celltrion Healthcare Covid-19 Rapid Antigen Basic Information
Table 87. Celltrion Healthcare Covid-19 Rapid Antigen Product Overview
Table 88. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Celltrion Healthcare Business Overview
Table 90. Celltrion Healthcare Recent Developments
Table 91. Salofa Oy Covid-19 Rapid Antigen Basic Information
Table 92. Salofa Oy Covid-19 Rapid Antigen Product Overview
Table 93. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Salofa Oy Business Overview
Table 95. Salofa Oy Recent Developments
Table 96. iHealth Labs Covid-19 Rapid Antigen Basic Information
Table 97. iHealth Labs Covid-19 Rapid Antigen Product Overview
Table 98. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. iHealth Labs Business Overview
Table 100. iHealth Labs Recent Developments
Table 101. Novegent Covid-19 Rapid Antigen Basic Information
Table 102. Novegent Covid-19 Rapid Antigen Product Overview
Table 103. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Novegent Business Overview
Table 105. Novegent Recent Developments
Table 106. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Basic Information
Table 107. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Overview
Table 108. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Hangzhou Alltest Biotech Business Overview
Table 110. Hangzhou Alltest Biotech Recent Developments
Table 111. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Basic Information
Table 112. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Overview
Table 113. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Guangzhou Decheng Biotechnology Business Overview
Table 115. Guangzhou Decheng Biotechnology Recent Developments
Table 116. SD Biosensor Covid-19 Rapid Antigen Basic Information
Table 117. SD Biosensor Covid-19 Rapid Antigen Product Overview
Table 118. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. SD Biosensor Business Overview
Table 120. SD Biosensor Recent Developments
Table 121. MP Biomedical Covid-19 Rapid Antigen Basic Information
Table 122. MP Biomedical Covid-19 Rapid Antigen Product Overview
Table 123. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. MP Biomedical Business Overview
Table 125. MP Biomedical Recent Developments
Table 126. Jiangsu Well Biotech Covid-19 Rapid Antigen Basic Information
Table 127. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Overview
Table 128. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Jiangsu Well Biotech Business Overview
Table 130. Jiangsu Well Biotech Recent Developments
Table 131. CTK Biotech Covid-19 Rapid Antigen Basic Information
Table 132. CTK Biotech Covid-19 Rapid Antigen Product Overview
Table 133. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. CTK Biotech Business Overview
Table 135. CTK Biotech Recent Developments
Table 136. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Basic Information
Table 137. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Overview
Table 138. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Hangzhou Laihe Biotech Business Overview
Table 140. Hangzhou Laihe Biotech Recent Developments
Table 141. Innovation Scientific Covid-19 Rapid Antigen Basic Information
Table 142. Innovation Scientific Covid-19 Rapid Antigen Product Overview
Table 143. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Innovation Scientific Business Overview
Table 145. Innovation Scientific Recent Developments
Table 146. Biohit Healthcare Covid-19 Rapid Antigen Basic Information
Table 147. Biohit Healthcare Covid-19 Rapid Antigen Product Overview
Table 148. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Biohit Healthcare Business Overview
Table 150. Biohit Healthcare Recent Developments
Table 151. ACON Biotech Covid-19 Rapid Antigen Basic Information
Table 152. ACON Biotech Covid-19 Rapid Antigen Product Overview
Table 153. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. ACON Biotech Business Overview
Table 155. ACON Biotech Recent Developments
Table 156. Assure Tech Covid-19 Rapid Antigen Basic Information
Table 157. Assure Tech Covid-19 Rapid Antigen Product Overview
Table 158. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Assure Tech Business Overview
Table 160. Assure Tech Recent Developments
Table 161. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Basic Information
Table 162. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Overview
Table 163. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Hangzhou Clongene Biotech Business Overview
Table 165. Hangzhou Clongene Biotech Recent Developments
Table 166. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Basic Information
Table 167. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Overview
Table 168. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Hangzhou Testsea Biotechnology Business Overview
Table 170. Hangzhou Testsea Biotechnology Recent Developments
Table 171. Global Covid-19 Rapid Antigen Sales Forecast by Region (2025-2030) & (K Units)
Table 172. Global Covid-19 Rapid Antigen Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)
Table 174. North America Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)
Table 176. Europe Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Covid-19 Rapid Antigen Sales Forecast by Region (2025-2030) & (K Units)
Table 178. Asia Pacific Covid-19 Rapid Antigen Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Covid-19 Rapid Antigen Sales Forecast by Country (2025-2030) & (K Units)
Table 180. South America Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Covid-19 Rapid Antigen Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Covid-19 Rapid Antigen Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Covid-19 Rapid Antigen Sales Forecast by Type (2025-2030) & (K Units)
Table 184. Global Covid-19 Rapid Antigen Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Covid-19 Rapid Antigen Price Forecast by Type (2025-2030) & (USD/Unit)
Table 186. Global Covid-19 Rapid Antigen Sales (K Units) Forecast by Application (2025-2030)
Table 187. Global Covid-19 Rapid Antigen Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Covid-19 Rapid Antigen
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Covid-19 Rapid Antigen Market Size (M USD), 2019-2030
Figure 5. Global Covid-19 Rapid Antigen Market Size (M USD) (2019-2030)
Figure 6. Global Covid-19 Rapid Antigen Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Covid-19 Rapid Antigen Market Size by Country (M USD)
Figure 11. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2023
Figure 12. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2023
Figure 13. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Covid-19 Rapid Antigen Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Covid-19 Rapid Antigen Market Share by Type
Figure 18. Sales Market Share of Covid-19 Rapid Antigen by Type (2019-2024)
Figure 19. Sales Market Share of Covid-19 Rapid Antigen by Type in 2023
Figure 20. Market Size Share of Covid-19 Rapid Antigen by Type (2019-2024)
Figure 21. Market Size Market Share of Covid-19 Rapid Antigen by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Covid-19 Rapid Antigen Market Share by Application
Figure 24. Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)
Figure 25. Global Covid-19 Rapid Antigen Sales Market Share by Application in 2023
Figure 26. Global Covid-19 Rapid Antigen Market Share by Application (2019-2024)
Figure 27. Global Covid-19 Rapid Antigen Market Share by Application in 2023
Figure 28. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2019-2024)
Figure 29. Global Covid-19 Rapid Antigen Sales Market Share by Region (2019-2024)
Figure 30. North America Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Covid-19 Rapid Antigen Sales Market Share by Country in 2023
Figure 32. U.S. Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Covid-19 Rapid Antigen Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Covid-19 Rapid Antigen Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2023
Figure 37. Germany Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region in 2023
Figure 44. China Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 50. South America Covid-19 Rapid Antigen Sales Market Share by Country in 2023
Figure 51. Brazil Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Covid-19 Rapid Antigen Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Covid-19 Rapid Antigen Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Covid-19 Rapid Antigen Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Covid-19 Rapid Antigen Market Share Forecast by Type (2025-2030)
Figure 65. Global Covid-19 Rapid Antigen Sales Forecast by Application (2025-2030)
Figure 66. Global Covid-19 Rapid Antigen Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Covid-19 Rapid Antigen
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Covid-19 Rapid Antigen Market Size (M USD), 2019-2030
Figure 5. Global Covid-19 Rapid Antigen Market Size (M USD) (2019-2030)
Figure 6. Global Covid-19 Rapid Antigen Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Covid-19 Rapid Antigen Market Size by Country (M USD)
Figure 11. Covid-19 Rapid Antigen Sales Share by Manufacturers in 2023
Figure 12. Global Covid-19 Rapid Antigen Revenue Share by Manufacturers in 2023
Figure 13. Covid-19 Rapid Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Covid-19 Rapid Antigen Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Covid-19 Rapid Antigen Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Covid-19 Rapid Antigen Market Share by Type
Figure 18. Sales Market Share of Covid-19 Rapid Antigen by Type (2019-2024)
Figure 19. Sales Market Share of Covid-19 Rapid Antigen by Type in 2023
Figure 20. Market Size Share of Covid-19 Rapid Antigen by Type (2019-2024)
Figure 21. Market Size Market Share of Covid-19 Rapid Antigen by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Covid-19 Rapid Antigen Market Share by Application
Figure 24. Global Covid-19 Rapid Antigen Sales Market Share by Application (2019-2024)
Figure 25. Global Covid-19 Rapid Antigen Sales Market Share by Application in 2023
Figure 26. Global Covid-19 Rapid Antigen Market Share by Application (2019-2024)
Figure 27. Global Covid-19 Rapid Antigen Market Share by Application in 2023
Figure 28. Global Covid-19 Rapid Antigen Sales Growth Rate by Application (2019-2024)
Figure 29. Global Covid-19 Rapid Antigen Sales Market Share by Region (2019-2024)
Figure 30. North America Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Covid-19 Rapid Antigen Sales Market Share by Country in 2023
Figure 32. U.S. Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Covid-19 Rapid Antigen Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Covid-19 Rapid Antigen Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2023
Figure 37. Germany Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Covid-19 Rapid Antigen Sales Market Share by Region in 2023
Figure 44. China Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 50. South America Covid-19 Rapid Antigen Sales Market Share by Country in 2023
Figure 51. Brazil Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Covid-19 Rapid Antigen Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Covid-19 Rapid Antigen Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Covid-19 Rapid Antigen Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Covid-19 Rapid Antigen Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Covid-19 Rapid Antigen Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Covid-19 Rapid Antigen Market Share Forecast by Type (2025-2030)
Figure 65. Global Covid-19 Rapid Antigen Sales Forecast by Application (2025-2030)
Figure 66. Global Covid-19 Rapid Antigen Market Share Forecast by Application (2025-2030)
